Quote | Ensysce Biosciences Inc Warrants (05/12/2019) (OTCMKTS:ENSCW)
Last: | $0.018 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0197 |
Close: | $0.018 |
High: | $0.02 |
Low: | $0.018 |
Volume: | 58,489 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Ensysce Biosciences Inc Warrants (05/12/2019) (OTCMKTS:ENSCW)
~ PF614-MPAR to be the Industry's First Overdose Protection Pain Product ~ SAN DIEGO, CA / ACCESSWIRE / January 25, 2023 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC), (OTC PINK:ENSCW), a clinical-stage biotech company applying transformative chemistry to improve pre...
SAN DIEGO, CA / ACCESSWIRE / January 11, 2023 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC PINK:ENSCW), a clinical-stage biotech company applying transformative chemistry to improve prescription drug safety to reduce abuse and overdose, today issued a letter to shar...
Message Board Posts | Ensysce Biosciences Inc Warrants (05/12/2019) (OTCMKTS:ENSCW)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Ensysce Biosciences Inc Warrants (05/12/2019) Company Name:
ENSCW Stock Symbol:
OTCMKTS Market:
~ PF614-MPAR to be the Industry's First Overdose Protection Pain Product ~ SAN DIEGO, CA / ACCESSWIRE / January 25, 2023 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC), (OTC PINK:ENSCW), a clinical-stage biotech company applying transformative chemistry to improve pre...
SAN DIEGO, CA / ACCESSWIRE / January 11, 2023 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC PINK:ENSCW), a clinical-stage biotech company applying transformative chemistry to improve prescription drug safety to reduce abuse and overdose, today issued a letter to shar...
Data Expected in March 2023 SAN DIEGO, CA / ACCESSWIRE / January 4, 2023 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC, OTC:ENSCW), a clinical-stage biotech company applying transformative chemistry to improve prescription drug safety to reduce abuse and overdose, tod...